Skip to content
OpenCapital
Get started

ENDRA Life Sciences Inc. NDRA Q4 2025 Annual earnings

Reported March 31, 2026

EPS-$3.26Miss by $2.03
Revenue estimate$100.0K
EPS estimate-$1.23

Next report

Aug 13, 2026 (In 2 weeks)
Revenue estimate$100.0K
EPS estimate-$0.84

Versus estimates

Revenue

Q4 2024$211.6K

Diluted EPS

Q1 2026-$1.09Beat by $0.14
Q4 2025-$3.26Miss by $2.03
Q3 2025-$1.75Beat by $0.20Q2 2025-$1.71Beat by $0.56Q1 2025-$2.59Beat by $1.32Q4 2024-$9.40Miss by $5.30

Ask the moment ENDRA Life Sciences Inc. reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did ENDRA Life Sciences Inc. report Q4 2025 earnings?
ENDRA Life Sciences Inc. (NDRA) reported Q4 2025 earnings on March 31, 2026.
What were ENDRA Life Sciences Inc.'s Q4 2025 revenue and EPS?
ENDRA Life Sciences Inc. reported eps of $-3.26 for Q4 2025.
Did ENDRA Life Sciences Inc. beat estimates in Q4 2025?
EPS missed the consensus estimate of $-1.23 by $2.03.
How did ENDRA Life Sciences Inc.'s Q4 2025 results compare year-over-year?
Compared to the same quarter a year prior, eps grew 65.3% from $-9.40.
Where can I find ENDRA Life Sciences Inc.'s Q4 2025 SEC filings?
You can read the 8-K earnings release (0001213900-26-037497) and the 10-K periodic report (0001213900-26-037617) directly on SEC EDGAR. The filing index links above go to sec.gov.